동맥 캐뉼라 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Arterial Cannula Market size is expected to reach USD 57.86 Million in 2034 from USD 29.70 Million (2025) growing at a CAGR of 7.69% during 2026-2034.

The Global Arterial Cannula Market is experiencing steady growth, driven by increasing cardiovascular surgeries and critical care procedures worldwide. Arterial cannulas are essential medical devices used in cardiopulmonary bypass and extracorporeal circulation procedures. The rising prevalence of heart diseases and the growing number of complex surgical interventions have significantly contributed to increased product demand.

Major growth drivers include advancements in minimally invasive surgical techniques and improvements in healthcare infrastructure. Technological innovations aimed at enhancing patient safety and reducing complications are strengthening market expansion. The aging population, particularly in developed countries, is also increasing the need for cardiac procedures. Furthermore, expanding access to healthcare services in emerging economies is creating new opportunities for manufacturers.

Looking forward, the market is expected to grow steadily with the advancement of cardiac care technologies and rising healthcare investments. Development of biocompatible materials and improved design features will enhance product performance. Increasing awareness about early cardiac intervention will further support demand. As cardiovascular disease remains a leading global health concern, the Arterial Cannula Market is positioned for long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Size

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

By Application

• Cardiopulmonary Bypass Surgery
• Extracorporeal Membrane Oxygenation
• Other Applications

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Andocor, B Braun, Becton Dickinson and Company, Edwards Lifesciences, Freelife Medical, Fresenius Medical Care, Getinge, ICU Medical, Kangxin Medical, LivaNova, Medtronic, Nipro Corporation, Polymedicure, Surgical Holdings, Terumo Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTERIAL CANNULA MARKET: BY SIZE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Size
• 4.2. 14-16 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. 17-19 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. 20-22 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. 23-25 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. 26-28 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. 29-31 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. 32-34 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. 35-36 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTERIAL CANNULA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiopulmonary Bypass Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Extracorporeal Membrane Oxygenation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTERIAL CANNULA MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTERIAL CANNULA MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Size
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Size
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Size
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Size
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Size
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTERIAL CANNULA INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Andocor
  • 9.2.2 B. Braun
  • 9.2.3 Becton Dickinson And Company
  • 9.2.4 Edwards Lifesciences
  • 9.2.5 Freelife Medical
  • 9.2.6 Fresenius Medical Care
  • 9.2.7 Getinge
  • 9.2.8 ICU Medical
  • 9.2.9 Kangxin Medical
  • 9.2.10 LivaNova
  • 9.2.11 Medtronic
  • 9.2.12 Nipro Corporation
  • 9.2.13 Polymedicure
  • 9.2.14 Surgical Holdings
  • 9.2.15 Terumo Corporation